TY - JOUR
T1 - Risk factors, prevalence, and site concordance of human papillomavirus in high-risk Greek men
AU - Tsikis, Savas
AU - Hoefer, Lea
AU - Bethimoutis, George
AU - Nicolaidou, Electra
AU - Paparizos, Vassilios
AU - Antoniou, Christina
AU - Chardalias, Leonidas
AU - Stavropoulos, Georgios Emmanouil
AU - Sharma, Shruti
AU - Long, Bradley C.
AU - Mujacic, Ibro
AU - Kadri, Sabah
AU - Segal, Jeremy P.
AU - Furtado, Larissa V.
AU - Schneider, John
AU - Charnot-Katsikas, Angella
N1 - Funding Information:
This study was funded in part by the National Institutes of Health (R21 AI118998, R01 DA033875), the National Center for Advancing Translational Sciences of the National Institutes of Health (UL1 TR000430), and the University of Chicago Pritzker School of Medicine Summer Research Project fund.
Publisher Copyright:
© 2018 Wolters Kluwer Health, Inc. All rights reserved.
PY - 2018/9/1
Y1 - 2018/9/1
N2 - The aim of this study was to determine the risk factors, genotype-specific prevalence, and concordance of human papillomavirus (HPV) infections at three anatomical sites in a cohort of high-risk Greek men. Patients were recruited from sexually transmitted infection and HIV clinics in Athens. Samples were obtained from oral, penile, and anal sites of 294 study participants and HPV testing was performed on 882 samples using next-generation sequencing. Patients also completed a questionnaire assessing risk factors for infection. The mean age of the participants was 33.1, 30% identified as men who have sex with men (MSM), and 21% were HIV positive. The prevalence of HPV was 49%; it was the highest at anal sites (33%) compared with 23% at penile sites (P=0.008) and 4% at oral sites (P<0.001). The most common HPV types in order of frequency were 6, 44, 16, 53, and 89. The genotype concordance rate was the highest between the penile and anal sites (7%), followed by 2% for anal-oral concordance. Identifying as MSM [adjusted odds ratios (aOR)=6.75, P<0.001] and being HIV positive (aOR=2.89, P=0.026) were significant risk factors for anal HPV infection, whereas alcohol use (aOR=0.45, P=0.002) was associated negatively with infection. The only significant risk factor for oral infection was an older age of sexual debut (aOR=1.32, P=0.038). Nearly half of our study participants tested positive in at least one of three anatomical sites. Using next-generation sequencing, we could identify high-risk types that are not covered by the current vaccine and would be missed by traditional HPV testing kits.
AB - The aim of this study was to determine the risk factors, genotype-specific prevalence, and concordance of human papillomavirus (HPV) infections at three anatomical sites in a cohort of high-risk Greek men. Patients were recruited from sexually transmitted infection and HIV clinics in Athens. Samples were obtained from oral, penile, and anal sites of 294 study participants and HPV testing was performed on 882 samples using next-generation sequencing. Patients also completed a questionnaire assessing risk factors for infection. The mean age of the participants was 33.1, 30% identified as men who have sex with men (MSM), and 21% were HIV positive. The prevalence of HPV was 49%; it was the highest at anal sites (33%) compared with 23% at penile sites (P=0.008) and 4% at oral sites (P<0.001). The most common HPV types in order of frequency were 6, 44, 16, 53, and 89. The genotype concordance rate was the highest between the penile and anal sites (7%), followed by 2% for anal-oral concordance. Identifying as MSM [adjusted odds ratios (aOR)=6.75, P<0.001] and being HIV positive (aOR=2.89, P=0.026) were significant risk factors for anal HPV infection, whereas alcohol use (aOR=0.45, P=0.002) was associated negatively with infection. The only significant risk factor for oral infection was an older age of sexual debut (aOR=1.32, P=0.038). Nearly half of our study participants tested positive in at least one of three anatomical sites. Using next-generation sequencing, we could identify high-risk types that are not covered by the current vaccine and would be missed by traditional HPV testing kits.
KW - Greece
KW - concordance
KW - high risk
KW - human papillomavirus
KW - men
KW - prevalence
KW - risk factors
UR - http://www.scopus.com/inward/record.url?scp=85017218347&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85017218347&partnerID=8YFLogxK
U2 - 10.1097/CEJ.0000000000000366
DO - 10.1097/CEJ.0000000000000366
M3 - Article
C2 - 28394804
AN - SCOPUS:85017218347
SN - 0959-8278
VL - 27
SP - 514
EP - 520
JO - European Journal of Cancer Prevention
JF - European Journal of Cancer Prevention
IS - 5
ER -